Elevated plasma levels of tissue factor as a valuable diagnostic biomarker with relevant efficacy for prediction of breast cancer morbidity

• Autorzy: Zarychta E. , Rhone P. , Bielawski K. , Rosc D. , Szot K. , Zdunska M. , Ruszkowska-Ciastek B.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

tissue factor pathway inhibitor; vascular endothelial growth factor-A; breast cancer; morbidity; patient; angiogenesis; hemostasis

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2018
• Tom: 69
• Numer: 6
• Opis fizyczny: p.921-931,fig.,ref.

Twórcy

autor

Zarychta E.

• Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, 9 Sklodowskiej-Curie Street, 85-094 Bydgoszcz, Poland
• The Holy Family Specialist Hospital, Warsaw, Poland

autor

Rhone P.

• Clinical Ward of Breast Cancer and Reconstructive Surgery, Oncology Centre Prof. F. Lukaszczyk Memorial Hospital in Bydgoszcz, Bydgoszcz, Poland

autor

Bielawski K.

• Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland

autor

Rosc D.

• Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland

autor

Szot K.

• Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland

autor

Zdunska M.

• Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland

autor

Ruszkowska-Ciastek B.

• Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland

Identyfikatory

DOI

10.26402/jpp.2018.6.06